SAHA SAURABH
Insider CIK 1861926 · CLVT Director · CNTA Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLVT CLARIVATE PLC | A Award | 2026-05-14 | 2026-05-15 | 62,264 | — | $0 | 170,601 | SEC↗ |
| CLVT CLARIVATE PLC | F Tax w/h | 2026-05-13 | 2026-05-15 | 8,178 | $2.44 | $20.0K | 108,337 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-07-21 | 2025-07-21 | 55,000 | — | $0 | 150,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-07-21 | 2025-07-21 | 55,000 | $15.92 | $875.6K | 221,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-07-21 | 2025-07-21 | 55,000 | $3.85 | $211.8K | 276,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-06-20 | 2025-06-20 | 55,000 | — | $0 | 205,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-06-20 | 2025-06-20 | 55,000 | $3.85 | $211.8K | 276,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-06-20 | 2025-06-20 | 55,000 | $12.63 | $694.6K | 221,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-05-20 | 2025-05-20 | 55,000 | — | $0 | 260,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-05-20 | 2025-05-20 | 55,000 | $12.71 | $699.0K | 221,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-05-20 | 2025-05-20 | 55,000 | $3.85 | $211.8K | 276,017 | SEC↗ |
| CLVT CLARIVATE PLC | A Award | 2025-05-07 | 2025-05-08 | 39,473 | — | $0 | 116,515 | SEC↗ |
| CLVT CLARIVATE PLC | F Tax w/h | 2025-05-06 | 2025-05-08 | 4,974 | $4.17 | $20.7K | 77,042 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-04-22 | 2025-04-22 | 40,344 | $12.43 | $501.5K | 221,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-04-21 | 2025-04-22 | 14,656 | $12.29 | $180.1K | 261,361 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-03-20 | 2025-03-21 | 55,000 | $16.69 | $918.0K | 276,017 | SEC↗ |
| CLVT CLARIVATE PLC | P Buy | 2025-03-03 | 2025-03-05 | 58,275 | $4.36 | $254.1K | 82,016 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-20 | 2025-02-20 | 775 | $16.54 | $12.8K | 331,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-02-20 | 2025-02-20 | 54,225 | $15.92 | $863.3K | 331,792 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-02-03 | 2025-02-04 | 900,000 | — | $0 | 900,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2025-02-01 | 2025-02-04 | 43,381 | $16.92 | $734.0K | 386,017 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-01-21 | 2025-01-22 | 53,375 | $15.76 | $841.2K | 431,023 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-01-21 | 2025-01-22 | 1,625 | $16.19 | $26.3K | 429,398 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-12-31 | 2024-12-31 | 36,263 | $16.35 | $592.9K | 484,398 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-20 | 2024-12-20 | 55,000 | $17.44 | $959.2K | 520,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-12-06 | 2024-12-06 | 87,496 | — | $0 | 3,869,485 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-12-06 | 2024-12-06 | 87,496 | $18.46 | $1.62M | 575,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-12-06 | 2024-12-06 | 87,496 | $5.84 | $511.0K | 663,157 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-11-25 | 2024-11-27 | 299 | — | $0 | 3,956,981 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-11-25 | 2024-11-27 | 299 | $5.84 | $1.7K | 575,960 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-11-25 | 2024-11-27 | 299 | $18.23 | $5.5K | 575,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-11-22 | 2024-11-22 | 1,671 | — | $0 | 3,957,280 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-11-22 | 2024-11-22 | 1,671 | $18.24 | $30.5K | 575,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-11-22 | 2024-11-22 | 1,671 | $5.84 | $9.8K | 577,332 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-11-21 | 2024-11-22 | 3,511 | — | $0 | 3,958,951 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-11-21 | 2024-11-22 | 3,511 | $18.24 | $64.0K | 575,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-11-21 | 2024-11-22 | 3,511 | $5.84 | $20.5K | 579,172 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-11-20 | 2024-11-22 | 55,000 | $16.89 | $929.0K | 575,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-11-13 | 2024-11-15 | 32,023 | — | $0 | 3,962,462 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-11-13 | 2024-11-15 | 32,023 | $5.84 | $187.0K | 662,684 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-11-13 | 2024-11-15 | 32,023 | $18.28 | $585.4K | 630,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-10-23 | 2024-10-23 | 2,592 | $15.32 | $39.7K | 630,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-10-22 | 2024-10-23 | 30,203 | $15.67 | $473.3K | 633,253 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-10-21 | 2024-10-23 | 22,205 | $15.80 | $350.8K | 663,456 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-09-30 | 2024-10-02 | 36,263 | $15.79 | $572.6K | 685,661 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-09-20 | 2024-09-20 | 55,000 | $16.53 | $909.2K | 721,924 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2024-09-10 | 2024-09-12 | 175,000 | — | $0 | 3,994,485 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2024-09-10 | 2024-09-12 | 175,000 | $5.84 | $1.02M | 951,924 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-09-10 | 2024-09-12 | 175,000 | $16.52 | $2.89M | 776,924 | SEC↗ |
| CLVT CLARIVATE PLC | S Sale | 2024-08-30 | 2024-09-04 | 17,646 | $6.75 | $119.1K | 23,741 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-08-23 | 2024-08-23 | 46,651 | $12.30 | $573.8K | 776,924 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-08-22 | 2024-08-22 | 506 | $12.23 | $6.2K | 823,575 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-08-21 | 2024-08-22 | 3,674 | $12.25 | $45.0K | 824,081 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2024-08-20 | 2024-08-22 | 4,169 | $12.32 | $51.4K | 827,755 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-06-30 | 2024-07-02 | 36,263 | $9.03 | $327.5K | 831,924 | SEC↗ |
| CLVT CLARIVATE PLC | A Award | 2024-05-07 | 2024-05-08 | 23,741 | — | $0 | 41,387 | SEC↗ |
| CLVT CLARIVATE PLC | F Tax w/h | 2024-05-06 | 2024-05-08 | 4,412 | $7.05 | $31.1K | 17,646 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-03-31 | 2024-04-02 | 36,263 | $11.30 | $409.8K | 868,187 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2024-02-01 | 2024-02-02 | 576,800 | — | $0 | 576,800 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2024-02-01 | 2024-02-02 | 144,200 | — | $0 | 930,773 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2024-02-01 | 2024-02-02 | 26,323 | $8.19 | $215.6K | 904,450 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-12-31 | 2024-01-02 | 36,263 | $7.96 | $288.7K | 786,573 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-09-30 | 2023-10-03 | 36,263 | $6.47 | $234.6K | 822,836 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-06-30 | 2023-07-03 | 36,263 | $5.90 | $214.0K | 859,099 | SEC↗ |
| CLVT CLARIVATE Plc | A Award | 2023-05-04 | 2023-05-08 | 22,058 | — | $0 | 22,058 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2023-03-31 | 2023-04-04 | 22,013 | $3.90 | $85.9K | 895,362 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2023-02-01 | 2023-02-03 | 315,000 | — | $0 | 315,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2023-02-01 | 2023-02-03 | 211,400 | — | $0 | 917,375 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2022-12-31 | 2023-01-04 | 44,025 | $3.10 | $136.5K | 705,975 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2022-07-01 | 2022-07-06 | 750,000 | — | $0 | 750,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2022-06-24 | 2022-06-27 | 10,000 | $4.63 | $46.3K | 38,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2022-02-02 | 2022-02-04 | 5,000 | $9.74 | $48.7K | 28,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2022-02-01 | 2022-02-03 | 750,000 | — | $0 | 750,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-11-16 | 2021-11-18 | 23,000 | $12.28 | $282.4K | 23,000 | SEC↗ |